Lin7a Antibody

What is LIN7A and what cellular functions does it regulate?

LIN7A (Lin-7 Homolog A) is a polarity protein that plays critical roles in establishing and maintaining apico-basal cell polarity. It contains a PDZ domain that facilitates protein-protein interactions with various binding partners involved in cellular organization and signaling . LIN7A is a component of the Crumbs polarity complex, which is essential for proper epithelial organization and tissue architecture .

Research has demonstrated that LIN7A regulates several key cellular functions:

• Establishment and maintenance of apico-basal cell polarity

• Formation of intercellular junctions

• Protein trafficking and localization of signaling molecules

• Lumen formation in three-dimensional epithelial structures

• Cell proliferation through activation of signaling pathways including PI3K/AKT

The importance of LIN7A extends beyond basic cellular organization, as its dysregulation has been implicated in pathological conditions including carcinogenesis and developmental abnormalities .

What are the optimal fixation and permeabilization protocols for LIN7A immunofluorescence?

When conducting immunofluorescence experiments to detect LIN7A, optimal sample preparation is essential for preserving protein localization and epitope accessibility. Based on successful protocols from published studies:

• Fixation recommendations:

  • 4% paraformaldehyde (PFA) for 15-20 minutes at room temperature for cultured cells

  • For tissue sections, 4% PFA overnight at 4°C followed by cryoprotection in 30% sucrose

• Permeabilization protocols:

  • 0.1-0.2% Triton X-100 in PBS for 10 minutes at room temperature

  • Alternatively, 0.5% saponin can be used for more gentle permeabilization

• Blocking conditions:

  • 5-10% normal serum (species matched to secondary antibody) with 1% BSA in PBS for 1 hour at room temperature

• Antibody incubation:

  • Primary antibody dilutions typically range from 1:100 to 1:500 in blocking solution

  • Overnight incubation at 4°C yields optimal signal-to-noise ratio

  • Secondary antibody incubation for 1-2 hours at room temperature

This protocol helps preserve the subcellular localization of LIN7A, which typically shows enrichment at cell-cell junctions and specific membrane domains in polarized epithelial cells .

How should researchers validate the specificity of LIN7A antibodies?

Proper validation of LIN7A antibodies is critical for ensuring experimental reliability. A comprehensive validation approach should include:

• Positive and negative controls:

  • Positive control: Cell lines or tissues known to express LIN7A (e.g., polarized epithelial cells)

  • Negative control: LIN7A-depleted cells using validated siRNA or shRNA constructs targeting LIN7A

• Multiple detection methods:

  • Western blotting: Should show a specific band at the expected molecular weight (~23 kDa for human LIN7A)

  • Immunofluorescence: Should demonstrate expected subcellular localization

  • Immunoprecipitation: Should pull down LIN7A and its known binding partners

• Cross-validation with multiple antibodies:

  • Using antibodies from different sources targeting different epitopes

  • Comparing monoclonal and polyclonal antibodies

• Recombinant protein controls:

  • Testing against purified recombinant LIN7A protein (available with various tags including Myc-DYKDDDDK, His, GST, and Strep tags)

  • Preabsorption of antibody with recombinant protein should abolish specific signals

• Genetic approaches:

  • Testing in knockout/knockdown models using targeted constructs such as pSUPER-mLin7A#1 (targeting sequence: 5′-GTGTATCAATACATGCATG-3′) or pSUPER-mLin7A#2 (targeting sequence: 5′-GTTGAACTGCCAAAGACTG-3′)

Implementing these validation steps will help ensure that experimental findings accurately reflect the biology of LIN7A rather than antibody artifacts.

How can researchers effectively study the role of LIN7A in cancer cell invasion and metastasis?

Investigating LIN7A's role in cancer cell invasion requires a multi-faceted approach combining molecular manipulation, functional assays, and in vivo models. Based on current research methodologies:

• Genetic manipulation strategies:

  • Stable knockdown using shRNA or CRISPR/Cas9 systems

  • Overexpression of wild-type LIN7A or domain-specific mutants

  • Creation of tagged variants for tracking protein dynamics

• In vitro invasion assays:

  • 3D spheroid invasion assays: Embed cellular spheroids in Matrigel and measure radial invasion

  • Transwell Matrigel invasion assays: Quantify cells traversing Matrigel-coated membranes

  • Real-time cell invasion monitoring systems

• Cellular polarity assessment:

  • Investigate acini formation in 3D culture systems

  • Monitor lumen formation and clearance using apoptotic markers (e.g., active caspase-3)

  • Assess apico-basal polarization using markers for different membrane domains

• Molecular pathway analysis:

  • Evaluate activation states of signaling pathways including PI3K/AKT and MAPK/ERK

  • Investigate β-catenin pathway activation through subcellular localization and target gene expression

  • Measure matrix metalloproteinase activity using zymography (particularly MMP-2 and MMP-9)

• In vivo models:

  • Orthotopic xenograft models (e.g., mammary fat pad injection for breast cancer studies)

  • Intracranial implantation for glioblastoma studies

  • Monitoring of tumor growth, invasion patterns, and metastatic spread

Research has demonstrated that LIN7A overexpression promotes proliferation, tumor growth, and invasion in breast cancer models, with LIN7A-overexpressing tumors growing earlier and faster compared to control tumors . Conversely, in glioblastoma U87 cells, silencing LIN7A may promote invasion through disruption of intercellular junctions and activation of the β-catenin pathway .

What protocols yield optimal results for co-immunoprecipitation of LIN7A and its binding partners?

Co-immunoprecipitation (co-IP) experiments require careful optimization to preserve protein-protein interactions involving LIN7A. The following protocol has been optimized based on successful research applications:

• Lysis buffer composition:

  • Base buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA

  • Detergent: 0.5-1% NP-40 or 0.5% Triton X-100 (gentler detergents preserve interactions)

  • Protease inhibitors: Complete protease inhibitor cocktail

  • Phosphatase inhibitors: 1 mM sodium orthovanadate, 10 mM sodium fluoride

  • Additional components: 1 mM DTT, 5% glycerol

• Cell lysis procedure:

  • Harvest cells in cold PBS

  • Lyse in cold lysis buffer for 30 minutes on ice with occasional gentle mixing

  • Centrifuge at 14,000 × g for 15 minutes at 4°C

  • Pre-clear lysate with protein A/G beads for 1 hour at 4°C

• Immunoprecipitation steps:

  • Incubate pre-cleared lysate with 2-5 μg of LIN7A antibody overnight at 4°C with gentle rotation

  • Add protein A/G beads and incubate for 2-4 hours at 4°C

  • Wash beads 4-5 times with wash buffer (lysis buffer with reduced detergent concentration)

  • Elute bound proteins with SDS sample buffer or specific elution buffer for downstream applications

• Controls and verification:

  • Input control: 5-10% of pre-cleared lysate

  • Negative control: Non-specific IgG of the same species as the LIN7A antibody

  • Reverse co-IP: Immunoprecipitate with antibodies against suspected binding partners

  • Validation by mass spectrometry for unbiased identification of interaction partners

This protocol is particularly effective for identifying LIN7A interactions with proteins involved in polarity complexes and signaling pathways that may contribute to cancer progression or developmental processes.

What are the major challenges in interpreting LIN7A knockdown phenotypes in different experimental systems?

Interpreting phenotypes resulting from LIN7A depletion presents several challenges that researchers should consider when designing experiments and analyzing results:

• Functional redundancy with other Lin7 isoforms:

  • Mammals express three Lin7 homologs (LIN7A, LIN7B, and LIN7C) with potentially overlapping functions

  • Compensatory upregulation of other isoforms may mask phenotypes in single knockdown experiments

  • Consider using combinatorial knockdown approaches or assessing expression changes in other isoforms

• Context-dependent functions:

  • LIN7A's roles may vary significantly between different cell types and tissues

  • In breast cancer cells, LIN7A overexpression promotes proliferation and invasion

  • In glioblastoma U87 cells, LIN7A silencing may promote invasion

  • In neural development, LIN7A depletion disrupts cerebral cortex development

• Temporal considerations:

  • Acute versus chronic depletion may yield different phenotypes

  • Developmental timing of knockdown can dramatically affect outcomes

  • Consider using inducible knockdown systems for temporal control

• Cellular polarity state:

  • Effects of LIN7A manipulation depend on the baseline polarity status of cells

  • Fully polarized epithelial cells versus mesenchymal or transformed cells may show opposite responses

  • 2D versus 3D culture systems often reveal different phenotypes

• Downstream pathway interactions:

  • Changes in LIN7A levels affect multiple signaling pathways, creating complex phenotypes

  • Pathway interactions may include PI3K/AKT, MAPK/ERK, and β-catenin signaling

  • Secondary effects on gene expression may complicate interpretation

To address these challenges, researchers should:

• Use multiple experimental systems and assays

• Incorporate rescue experiments with LIN7A variants

• Perform comprehensive analysis of related pathways

• Consider time-resolved experiments to capture dynamic changes

What are the optimal sample preparation methods for detecting LIN7A in various experimental contexts?

Sample preparation protocols must be tailored to the specific experimental context and detection method. The table below summarizes optimal preparation methods for different applications:

For all applications, samples should be kept cold during preparation and processed quickly to prevent protein degradation. When analyzing LIN7A in research contexts, it's important to consider its relatively small size (~23 kDa) and membrane association, which may affect extraction efficiency and detection sensitivity.

How can researchers quantitatively assess changes in LIN7A protein levels and localization?

Accurate quantification of LIN7A protein levels and localization changes is essential for understanding its functional roles. Several complementary approaches provide robust quantitative data:

• Western blot quantification:

  • Normalization to appropriate loading controls (β-actin, GAPDH, or tubulin)

  • Use of infrared fluorescence-based detection systems for wider linear range

  • Inclusion of standard curves using recombinant LIN7A protein

  • Recommended software: ImageJ, Image Studio Lite, or specialized analysis packages

• Quantitative immunofluorescence:

  • Subcellular distribution analysis using line scan profiles across cell boundaries

  • Colocalization analysis with markers of specific cellular compartments

  • Measurement of membrane-to-cytoplasm signal ratio

  • Z-stack confocal imaging for complete spatial assessment

• Biochemical fractionation:

  • Sequential extraction protocols to separate cytosolic, membrane, and nuclear fractions

  • Quantification of LIN7A distribution across fractions by Western blotting

  • Normalization to compartment-specific markers (e.g., Na+/K+ ATPase for membrane)

• High-content imaging analysis:

  • Automated microscopy systems for high-throughput quantification

  • Multi-parametric analysis of protein levels, localization, and cell morphology

  • Machine learning approaches for complex phenotypic classification

• FRET/BRET-based approaches:

  • For live-cell dynamics and protein-protein interaction studies

  • Requires generation of fluorescent protein-tagged LIN7A constructs

  • Enables real-time monitoring of changes in protein associations

Example quantification workflow for membrane localization:

• Perform immunofluorescence staining for LIN7A and membrane markers

• Acquire confocal z-stacks of multiple cells

• Measure colocalization using Pearson's or Manders' coefficients

• Compare coefficients across experimental conditions using appropriate statistical tests

Research has shown that alterations in LIN7A localization, particularly disruption of its membrane association, can dramatically affect cellular functions including polarity establishment and signaling pathway activation .

What considerations should be made when selecting a LIN7A antibody for specific applications?

Selection of the appropriate LIN7A antibody is critical for experimental success across different applications. Researchers should consider the following factors:

• Antibody type and specificity:

  • Monoclonal antibodies: Offer high specificity for a single epitope but may be sensitive to epitope masking

  • Polyclonal antibodies: Recognize multiple epitopes, providing robust detection but potentially higher background

  • Species reactivity: Ensure compatibility with your experimental system (human, mouse, rat, etc.)

  • Cross-reactivity assessment: Check for potential cross-reactivity with LIN7B and LIN7C

• Target epitope location:

  • N-terminal region: Contains L27 domain involved in protein-protein interactions

  • PDZ domain: Mediates interactions with transmembrane and cytoplasmic proteins

  • C-terminal region: May be exposed or buried depending on binding partners

  • Consider epitope accessibility in native protein conformation for IP applications

• Application-specific considerations:

• Available validation data:

  • Knockout/knockdown validation: Essential for confirming specificity

  • Peptide competition: Verifies epitope specificity

  • Published literature using the antibody in similar applications

  • Manufacturer validation data including Western blot images

• Technical specifications:

  • Host species: Consider compatibility with other antibodies in multi-labeling experiments

  • Conjugated options: Direct fluorophore conjugates may improve signal-to-noise ratio

  • Clonality and clone number: Important for reproducibility across experiments

For critical experiments, testing multiple antibodies in parallel is recommended to confirm findings and avoid antibody-specific artifacts.

How is LIN7A implicated in cancer progression and metastasis?

Recent research has uncovered significant roles for LIN7A in cancer biology, with evidence suggesting context-dependent functions across different cancer types:

• Breast cancer implications:

  • LIN7A is significantly overexpressed in invasive micropapillary carcinomas (IMPCs) compared to invasive carcinomas of no special type

  • Overexpression promotes hyperproliferation, invasion, and disruption of normal epithelial architecture

  • LIN7A-overexpressing tumors grow faster and larger in mouse xenograft models

  • Mechanistically linked to increased PI3K/AKT and MAPK/ERK signaling pathway activation

• Glioblastoma considerations:

  • LIN7A silencing may promote U87 tumor cell invasion by disrupting intercellular junctions

  • Altered LIN7A expression affects β-catenin pathway activation and localization

  • Influences matrix metalloproteinase activity (particularly MMP-2 and MMP-9)

  • Clinical data suggests differential expression in core versus peripheral invading areas of glioblastoma

• Cellular mechanisms of cancer promotion:

  • Disruption of cell polarity, a hallmark of carcinomas

  • Alteration of growth factor receptor trafficking and signaling

  • Modification of cell-cell adhesion properties

  • Influence on lumen formation and epithelial architecture

  • Potential impact on cancer stem cell maintenance

• Clinical correlations:

  • Expression patterns may have prognostic significance

  • Potential as a biomarker for specific cancer subtypes

  • Association with invasion and metastatic potential

  • Possible therapeutic target for polarity-restoring interventions

Current evidence suggests that LIN7A functions may be highly context-dependent, with both overexpression and silencing potentially promoting cancerous phenotypes depending on the cellular context and cancer type. This complexity highlights the need for careful investigation of LIN7A's role in specific cancer types and cellular environments.

What role does LIN7A play in neurological development and disorders?

LIN7A has emerged as a critical factor in neurological development, with implications for various neurological disorders:

• Developmental neurobiology:

  • LIN7A depletion disrupts cerebral cortex development

  • Involved in neuronal polarity establishment and maintenance

  • Contributes to synapse formation and neurotransmitter receptor localization

  • Plays roles in neuronal migration and cortical layering

• Molecular mechanisms in neurons:

  • LIN7A interacts with NMDA receptors and regulates their trafficking

  • Participates in the organization of the postsynaptic density

  • Forms complexes with other PDZ-domain proteins at synapses

  • Influences dendritic spine development and morphology

• Pathological implications:

  • Implicated in 12q21-deletion syndrome and intellectual disability

  • Potential involvement in neurodevelopmental disorders

  • May contribute to synaptic dysfunction in neurological conditions

  • Altered expression observed in certain brain pathologies

• Research approaches for neurological studies:

  • In utero electroporation for developmental studies

  • Primary neuronal cultures for detailed cellular analysis

  • Brain-specific conditional knockout models

  • Human induced pluripotent stem cell (iPSC) differentiation to neurons

• Therapeutic considerations:

  • Potential target for interventions in developmental disorders

  • Role in synaptic plasticity suggests relevance to learning and memory

  • Possible implications for regenerative approaches in neurological damage

Research targeting LIN7A in neurological contexts requires specialized techniques to address the complex architecture of neural tissues and the temporal dynamics of brain development. Investigators should consider using methods optimized for neural tissue, including specialized fixation protocols for immunohistochemistry and advanced imaging techniques for synaptic structures.

How do post-translational modifications regulate LIN7A function?

The regulation of LIN7A through post-translational modifications (PTMs) represents an emerging area of research with significant implications for understanding its dynamic cellular functions:

• Phosphorylation:

  • Multiple potential phosphorylation sites predicted in the LIN7A sequence

  • Phosphorylation may regulate protein-protein interactions, particularly PDZ domain binding

  • Could influence membrane association and subcellular trafficking

  • May respond to activation of signaling pathways including PI3K/AKT

• Ubiquitination:

  • Potential regulation of LIN7A protein stability and turnover

  • May be involved in activity-dependent remodeling of polarity complexes

  • Could influence LIN7A levels during cell cycle progression

  • Possibly dysregulated in pathological conditions

• SUMOylation:

  • May regulate nuclear-cytoplasmic distribution

  • Could influence interaction with transcription factors or nuclear proteins

  • Potential role in stress responses and cellular adaptation

• Methodological approaches for studying LIN7A PTMs:

  • Mass spectrometry-based proteomics for PTM site identification

  • Phospho-specific antibodies for targeted analysis

  • Mutagenesis of PTM sites to create constitutively active/inactive variants

  • Pharmacological inhibitors of specific kinases or other PTM enzymes

  • Dynamic live-cell imaging using fluorescent biosensors

• Functional consequences of PTMs:

  • Alteration of binding affinity for partner proteins

  • Changes in subcellular localization

  • Modification of protein stability and turnover rates

  • Integration of signals from multiple pathways

  • Temporal regulation during development or cell cycle

Understanding the PTM landscape of LIN7A will provide crucial insights into how this protein integrates signals from multiple cellular pathways to coordinate polarity, proliferation, and tissue architecture in normal development and disease states.

What are common problems encountered when using LIN7A antibodies and how can they be resolved?

Researchers working with LIN7A antibodies may encounter several technical challenges. Below are common issues and recommended solutions:

• Weak or absent signal in Western blotting:

  • Problem: Insufficient protein extraction, especially from membrane fractions

  • Solution: Use stronger lysis buffers containing 1% SDS, heating samples at 95°C for 10 minutes

  • Problem: Inefficient transfer of small proteins

  • Solution: Use PVDF membranes with smaller pore size (0.2 μm), shorter transfer time, or transfer buffers containing 20% methanol

• High background in immunofluorescence:

  • Problem: Non-specific antibody binding

  • Solution: Increase blocking time/concentration, use alternative blocking agents (e.g., fish gelatin)

  • Problem: Autofluorescence from fixatives

  • Solution: Quench with 0.1% sodium borohydride after fixation, or use Sudan Black B to reduce autofluorescence

• Inconsistent immunoprecipitation results:

  • Problem: Variable efficiency in pulling down LIN7A

  • Solution: Optimize antibody concentration and incubation conditions, consider cross-linking antibody to beads

  • Problem: Loss of protein-protein interactions

  • Solution: Use milder lysis conditions, reduce salt concentration, include protein crosslinkers

• Discrepancies between different detection methods:

  • Problem: Antibody works in Western blot but not immunofluorescence

  • Solution: Test different fixation and permeabilization methods, consider epitope masking in native conformation

  • Problem: Differences between cell types or tissues

  • Solution: Optimize protocols for each specific sample type, consider context-dependent protein interactions

• Non-specific bands or signals:

  • Problem: Cross-reactivity with related proteins (LIN7B/C)

  • Solution: Validate with LIN7A knockdown controls, use monoclonal antibodies targeting unique epitopes

  • Problem: Degradation products appearing as multiple bands

  • Solution: Use fresh samples, include additional protease inhibitors, keep samples cold throughout processing

Systematic troubleshooting approach:

• Always include positive and negative controls

• Test multiple antibody dilutions and incubation conditions

• Compare results across different detection methods

• Validate findings with genetic approaches (knockdown/knockout)

• Consider the biological context when interpreting results

How can researchers design effective LIN7A knockdown experiments to avoid off-target effects?

Designing effective and specific LIN7A knockdown experiments requires careful consideration of multiple factors to minimize off-target effects and ensure reliable results:

• siRNA/shRNA design principles:

  • Design multiple targeting sequences (at least 3-4) against different regions of LIN7A mRNA

  • Avoid sequences with homology to other genes, particularly LIN7B and LIN7C

  • Use validated sequences from published studies when available, such as:

    • pSUPER-mLin7A#1: 5′-GTGTATCAATACATGCATG-3′ (targets position 202-220)

    • pSUPER-mLin7A#2: 5′-GTTGAACTGCCAAAGACTG-3′ (targets position 325-343)

  • Perform BLAST searches to confirm specificity of target sequences

  • Consider seed region complementarity to minimize microRNA-like off-target effects

• Control strategies:

  • Include non-targeting control siRNA/shRNA with similar GC content

  • Perform rescue experiments with RNAi-resistant LIN7A constructs

  • Use multiple independent siRNA/shRNA sequences and compare phenotypes

  • Include positive control siRNAs with well-characterized effects

• Validation of knockdown efficiency:

  • Assess LIN7A mRNA levels by RT-qPCR

  • Quantify protein reduction by Western blotting

  • Confirm subcellular localization changes by immunofluorescence

  • Verify functional consequences through appropriate assays

• CRISPR/Cas9 approaches:

  • Consider CRISPR/Cas9 for complete knockout studies

  • Design multiple gRNAs targeting early exons

  • Screen for off-target effects using whole-genome sequencing or targeted sequencing

  • Generate clonal lines and verify knockout by sequencing

• Temporal considerations:

  • Use inducible systems for temporal control of knockdown

  • Assess both acute and chronic effects

  • Monitor potential compensatory mechanisms by related proteins

• Dosage optimization:

  • Titrate siRNA/shRNA concentrations to achieve optimal knockdown with minimal off-target effects

  • Consider partial knockdown approaches to avoid complete loss-of-function

By implementing these design principles and controls, researchers can generate more reliable and reproducible LIN7A knockdown phenotypes that accurately reflect the protein's biological functions rather than experimental artifacts.

What technical challenges arise when studying LIN7A interactions with binding partners?

Investigating LIN7A protein-protein interactions presents several technical challenges that researchers should anticipate and address:

• Preserving transient or weak interactions:

  • Challenge: Many LIN7A interactions may be dynamic or of low affinity

  • Solution: Use chemical crosslinking (e.g., DSP, formaldehyde) prior to cell lysis

  • Solution: Optimize buffer conditions (salt, pH, detergent) to maintain specific interactions

  • Solution: Consider proximity labeling approaches (BioID, APEX) for capturing transient interactions

• Distinguishing direct from indirect interactions:

  • Challenge: Co-immunoprecipitation cannot distinguish direct binding from complex association

  • Solution: Perform in vitro binding assays with purified recombinant proteins

  • Solution: Use yeast two-hybrid or mammalian two-hybrid systems

  • Solution: Employ protein fragment complementation assays (split-GFP, split-luciferase)

• Maintaining structural integrity of domains:

  • Challenge: PDZ domain interactions are often disrupted by denaturation

  • Solution: Use mild solubilization conditions that preserve native protein structure

  • Solution: Consider membrane fractionation to enrich for intact complexes

  • Solution: Test domain-specific antibodies that may not disrupt interactions

• Detecting context-dependent interactions:

  • Challenge: LIN7A interactions may vary by cell type or physiological state

  • Solution: Compare interaction profiles across relevant cell types

  • Solution: Analyze interactions under different stimulation conditions

  • Solution: Consider in situ proximity ligation assays to detect endogenous interactions

• Technical approaches for comprehensive interaction mapping:

Successful characterization of LIN7A interactions requires combining multiple complementary approaches and carefully validating findings across different experimental systems. Particular attention should be paid to the possibility of context-dependent interactions that may vary across cell types or physiological conditions relevant to LIN7A's roles in development and disease.